Cargando…

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013

BACKGROUND: The majority of patients with chondrosarcoma of bone have an excellent overall survival after local therapy. However, in case of unresectable locally advanced or metastatic disease the outcome is poor and limited treatment options exist. Therefore we conducted a survey of clinical phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Maldegem, Annemiek M, Bovée, Judith VMG, Gelderblom, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131227/ https://www.ncbi.nlm.nih.gov/pubmed/25126409 http://dx.doi.org/10.1186/2045-3329-4-11

Ejemplares similares

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
por: Addie, Ruben D., et al.
Publicado: (2019)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors
por: Boeuf, Stephane, et al.
Publicado: (2012)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma
por: Palubeckaitė, Ieva, et al.
Publicado: (2020)

SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone
por: Kroonen, Jessie S., et al.
Publicado: (2021)

IDH Mutations in Chondrosarcoma: Case Closed or Not?
por: Venneker, Sanne, et al.
Publicado: (2023)

Multiple osteochondromas
por: Bovée, Judith VMG
Publicado: (2008)

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
por: de Groot, Stefanie, et al.
Publicado: (2017)

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
por: Venneker, Sanne, et al.
Publicado: (2019)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)

Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in Chondrosarcoma
por: Olsson, Linda, et al.
Publicado: (2011)

Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000–2017 Netherlands Cancer Registry Database Analysis
por: Van Meekeren, Milan, et al.
Publicado: (2021)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Correction: Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in Chondrosarcoma
por: Olsson, Linda, et al.
Publicado: (2011)

Targeting survivin as a potential new treatment for chondrosarcoma of bone
por: de Jong, Y, et al.
Publicado: (2016)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
por: de Jong, Yvonne, et al.
Publicado: (2019)

Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis
por: Lam, Suk Wai, et al.
Publicado: (2019)

Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation
por: de Andrea, Carlos E., et al.
Publicado: (2011)

Clear Cell Chondrosarcoma of Bone
por: Ayoub, Khalid S., et al.
Publicado: (1999)

Myxoid chondrosarcoma of sphenoid bone
por: Chowhan, Amit K, et al.
Publicado: (2012)

Chondrosarcoma of bone in children and adolescents
por: Kaneuchi, Yoichi, et al.
Publicado: (2020)

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines
por: Suijker, Johnny, et al.
Publicado: (2015)

Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
por: Venneker, Sanne, et al.
Publicado: (2020)

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo
por: Suijker, Johnny, et al.
Publicado: (2015)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

A novel colony‐stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor
por: Lipplaa, Astrid, et al.
Publicado: (2023)

Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management
por: Hameetman, Liesbeth, et al.
Publicado: (2004)

Comprehensive bibliometric and visualized analysis of research on fecal microbial transplantation published from 2000 to 2021
por: Ma, Jing, et al.
Publicado: (2022)

Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study
por: Verschoor, Arie J, et al.
Publicado: (2018)

A Descriptive Analysis of Overviews of Reviews Published between 2000 and 2011
por: Hartling, Lisa, et al.
Publicado: (2012)

Publisher Correction: Mapping exclusive breastfeeding in Africa between 2000 and 2017
por: Bhattacharjee, Natalia V., et al.
Publicado: (2019)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Clinicopathological and histological behavior of mesenchymal chondrosarcoma involving maxilla
por: Kerketa, Mrinmoy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hkth7scqa9cv5nhiblvitvllqe